目录产品 » Cardiac troponin I (cTnI) Antibody (5C7HC)

cTnI (5C7HC)

Cardiac Troponin I (cTnI) is synthesized in cardiac muscle and forms a structural complex with Troponin T and C. Its concentration in blood increases after the onset of chest pain and maintains peak for a couple of weeks. The cTnI protein is considered as useful diagnosis marker for acute myocardial infarction (AMI).
询价
V00306-1

Specificity Specific to Human cTnI.
No cross-reactivity with human cTnT
Clone ID 5C7HC
Epitope 40-50 within cTnI protein
Isotype Recombinant human IgG1 for 5C7HC.
Subclass Recombinant Human IgG1
Host Species Recombinant Human IgG1
Antigen Species Human
返回

Conjugation Unconjugated
Production Cultured in vitro under conditions free from animal-derived components
Purification Protein A/G affinity column
Concentration ≥ 2mg/ml
Formulation 50 mM Na-citrate, 150 mM NaCl, pH 7.0, containing 0.03% ProClin 300.
Storage For long term storage, aliquot and store at -20°C or below. Avoid repeated freezing and thawing cycles.
Product Stability
Temperature, Time Result for clones
5C7 6D11 31D 32C
-80°C, 21 days OK
-20°C, 21 days OK
4°C, 21 days OK
20°C, 21 days OK
37°C, 21 days OK
40°C, 21 days OK
Note GenScript can customize this product per customer's request including product size, buffer components, etc.
返回

Platform Capture Detection
ELISA 32CD 5C7
32CD+6D11
(mixture for coating)
5C7
31D 32CD
5C7 6D11
CLIA 24E40HC 5C7HC
32CD+6D11 5C7HC
TRFIA 24E40HC 5C7HC
返回

CTnI (5C7HC)

»

<
>

Target Background Cardiac Troponin I (cTnI) is synthesized in cardiac muscle and forms a structural complex with Troponin T and C. Its concentration in blood increases after the onset of chest pain and maintains peak for a couple of weeks. The cTnI protein is considered as useful diagnosis marker for acute myocardial infarction (AMI).
返回

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.